Carlos Trujillo
Director of Finance/CFO at PHARMACYTE BIOTECH, INC.
Net worth: 22 048 $ as of 29/04/2024
Profile
Carlos A.
Trujillo is currently the Chief Financial Officer at PharmaCyte Biotech, Inc. He previously held the position of Chief Financial Officer at VelaTel Global Communications, Inc. from 2008 to 2014 and at California Cove Communities, Inc. in 2008.
He also worked as the Chief Financial Officer at Viridis Biotech, Inc. Mr. Trujillo obtained his undergraduate degree from California State University-Fullerton in 1982.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
PHARMACYTE BIOTECH, INC.
0.12% | 19/03/2024 | 10,400 ( 0.12% ) | 22 048 $ | 29/04/2024 |
Carlos Trujillo active positions
| Companies | Position | Start |
|---|---|---|
| PHARMACYTE BIOTECH, INC. | Director of Finance/CFO | 28/02/2017 |
Former positions of Carlos Trujillo
| Companies | Position | End |
|---|---|---|
| VELATEL GLOBAL COMMUNICATIONS INC | Director of Finance/CFO | 31/08/2014 |
| California Cove Communities, Inc. | Director of Finance/CFO | 31/12/2007 |
Viridis Biotech, Inc.
 Viridis Biotech, Inc. Pharmaceuticals: MajorHealth Technology Part of PharmaCyte Biotech, Inc., Viridis Biotech, Inc. develops biopharmaceutical products for the treatment of chronic diseases. The private company is based in Silver Spring, MD. The CEO of the company is Timothy M. Matula. | Director of Finance/CFO | - |
Training of Carlos Trujillo
| California State University-Fullerton | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| PHARMACYTE BIOTECH, INC. | Health Technology |
| Private companies | 3 |
|---|---|
VelaTel Global Communications, Inc.
 VelaTel Global Communications, Inc. Specialty TelecommunicationsCommunications VelaTel Global Communications, Inc. provides capital, engineering, architectural and construction services related to the build-out of wireless broadband telecommunications networks, which it then operates by offering services attractive to residential, enterprise and government subscribers. Its focus is on the deployment of telecommunications networks that utilize Wireless Broadband Access in emerging international markets. The company was founded on September 19, 2005 and is headquartered in Carlsbad, CA. | Communications |
| California Cove Communities, Inc. | |
Viridis Biotech, Inc.
Viridis Biotech, Inc. Pharmaceuticals: MajorHealth Technology Part of PharmaCyte Biotech, Inc., Viridis Biotech, Inc. develops biopharmaceutical products for the treatment of chronic diseases. The private company is based in Silver Spring, MD. The CEO of the company is Timothy M. Matula. | Health Technology |
- Stock Market
- Insiders
- Carlos Trujillo
